Solas BioVentures
Chattanooga, Tennesseesolasbio.com
Overview
Solas BioVentures is a venture capital firm that invests exclusively in the life sciences industry, focusing on early-stage biopharmaceuticals, medical devices, digital health technologies, and related opportunities in medicine. The firm maintains a founder-centric approach to enable breakthrough medicine and technology innovation, aiming to positively transform the standard of care and patient outcomes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Francis Medical | Jan 2025 | Series C | Lead |
| iO Urology | Mar 2024 | Series A | Lead |
| Vektor Medical | Feb 2024 | Series A | Lead |
| Basking Biosciences | Feb 2024 | Series C | Co-investor |
| Arrivo BioVentures | Nov 2023 | Series B | Co-investor |
Key People
C David Adair
Managing Partner Co-Founder
Mark Hackett
Managing Partner And Co-Founder
Lana B. Caron
General Partner
Michael Hoey
General Partner
Terry Adams
General Partner
MBA FFPM GFMD Laurent Pacheco
Investor Venture Partner
A. Travis Manasco
Principal
Joshua Eckelberry
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.